Regulation · EU
Commission Regulation (EU) 2026/876 of 21 April 2026 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, aclonifen, deltamethrin, oxathiapiprolin and potassium phosphonates in or on certain products
- Identifier
- CELEX 32026R0876
- Status
- in_force
- Adopted
- 21 April 2026
- Published
- 21 April 2026
- Language
- en
- Official source
- https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32026R0876
- Source provider
- eurlex
- Retrieved
- 2026-08-26T22:55:45.500Z
Identifier
- CELEX: 32026R0876 · eurlex
Direct relationships
PoliticalRepo: CELEX 32026R0876
- Identifier matchPROJECTS_FROM
Same CELEX 32026R0876 projected from PoliticalRepo EUR-Lex row 32026R0876.
LegalInstrument → PoliticalRecord · Open related record